ComPASS Collective for Community Engagement (C3E)
ComPASS Collective for Community Engagement (C3E)
批准号:
10903370
负责人:
Gordon R Bernard
金额:
$70.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-11 至 2024-02-29
关键词:
AcademyAddressApplications GrantsArchivesAreaAutomobile DrivingBiomedical ResearchCOVID-19Chronic DiseaseClinical ResearchClinical and Translational Science AwardsCommunitiesCommunity DevelopmentsComplexDataEnsureEquityExclusionFoundationsFundingFutureGoalsHealth SciencesHealthcareHybridsInfrastructureInstitutionInternetInterventionKnowledgeMeasuresMedicineMethodologyMethodsMinority-Serving InstitutionMissionModelingMulti-Institutional Clinical TrialNational Center for Advancing Translational SciencesNational Institute on Minority Health and Health DisparitiesNeeds AssessmentPatient-Focused OutcomesPharmaceutical PreparationsPoliciesPublic Health InformaticsRADxRecommendationResearchResearch InfrastructureResearch InstituteResearch PersonnelResource DevelopmentResourcesReview LiteratureRoleScienceSeriesSummary ReportsSystemTranslational ResearchTranslationsUnited States National Institutes of HealthVoicecommunity based participatory researchcommunity engaged researchcommunity engagementcommunity organizationscommunity partnershipdesignhealth equityhealth inequalitiesimprovedinformatics toolinnovationmarginalizationmarginalized populationmeetingsmultidimensional datanoveloperationpragmatic trialpreventprogramsresponsescience and societyskillssuccesstooltrial design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Vanderbilt Institute for Clinical and Translational Research (VICTR) is a highly functional and
integrated clinical and translational (C&T) research infrastructure that has raised the quality and
scientific rigor of the research conducted at Vanderbilt and longstanding partner Meharry, the
nation's oldest historically black academic health science institution. VICTR will contribute to the
mission of the CTSA program while leveraging unique resources and expertise within VICTR's
Hub and elevating the role of health equity in C&T research with these new aims: 1) Leverage
VICTR's strong collaborative energy to enhance team science methodologies, integrate
community engagement principles for all stages of research, and implement programs designed
to support health equity in research; 2) Develop and share multi-dimensional data organization
methods and informatics tools to promulgate innovation, efficiency, quality, and equity in research;
3) Ensure the translational science workforce is diverse and has the skills, knowledge, and
resources necessary to advance translation of discoveries within a health equity framework; 4)
Support the efficiency, quality, representativeness, and impact of local studies and `raise the bar'
for acceptable scientific standards in research conduct; 5) Support the efficiency, quality,
representativeness, and impact of multi-site clinical trials by building and disseminating
streamlining programs and promoting novel trial designs; and 6) Utilize unique institutional
capabilities to enable the conduct of pragmatic trials during healthcare operations and repurpose
existing drugs for new indications.
期刊论文(480)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.isci.2021.103602
发表时间:
2022-01-21
期刊:
iScience
影响因子:
5.8
作者:
[Gilchuk P, Thomsen I, Yoder S, Brady E, Chappell JD, Stevens LJ, Denison MR, Sutton RE, Chen RE, VanBlargan LA, Suryadevara N, Zost SJ, Schmitz J, Pulley JM, Diamond MS, Rhoads JP, Bernard GR, Self WH, Rice TW, Wheeler AP, Crowe JE Jr, Carnahan RH]
通讯作者:
Carnahan RH
DOI:
10.1080/00207144.2022.2096455
发表时间:
2022-07
期刊:
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS
影响因子:
1.7
作者:
[McKernan, Lindsey C., Finn, Michael T. M., Crofford, Leslie J., Kelly, A. Gracie, Patterson, David R., Jensen, Mark P.]
通讯作者:
Jensen, Mark P.
DOI:
10.1093/infdis/jiac442
发表时间:
2023-05-12
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1016/j.neubiorev.2017.08.018
发表时间:
2018-01
期刊:
Neuroscience and biobehavioral reviews
影响因子:
8.2
作者:
[Gandelman JA, Newhouse P, Taylor WD]
通讯作者:
Taylor WD
DOI:
10.1038/s41390-020-01303-7
发表时间:
2021-05
期刊:
Pediatric research
影响因子:
3.6
作者:
[Van Driest SL, Madell SM, Crum K, Smith AH, Bichell DP, Kannankeril PJ]
通讯作者:
Kannankeril PJ
共 266 条
Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC)
-
批准号:10650682
-
项目类别:
-
资助金额:$516.98万
-
财政年份:2023
-
负责人:Gordon R Bernard
-
依托单位:
Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)
-
批准号:10647455
-
项目类别:
-
资助金额:$228.71万
-
财政年份:2023
-
负责人:Gordon R Bernard
-
依托单位:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
-
批准号:10398799
-
项目类别:
-
资助金额:$158.37万
-
财政年份:2021
-
负责人:Gordon R Bernard
-
依托单位:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
-
批准号:10084583
-
项目类别:
-
资助金额:$158.37万
-
财政年份:2021
-
负责人:Gordon R Bernard
-
依托单位:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
-
批准号:10609049
-
项目类别:
-
资助金额:$158.37万
-
财政年份:2021
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasma
-
批准号:10254565
-
项目类别:
-
资助金额:$56.3万
-
财政年份:2020
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:10170009
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2020
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:9490464
-
项目类别:
-
资助金额:$799.21万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:9414517
-
项目类别:
-
资助金额:$802.06万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Passive Immunity Trial for Our Neighbors (PassITON): A randomized, placebo-controlled multi-site trial of anti-SARS-CoV-2 convalescent plasma to treat hospitalized adults with COVID-19
-
批准号:10218949
-
项目类别:
-
资助金额:$3400.0万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:10591572
-
项目类别:
-
资助金额:$1095.41万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:10523600
-
项目类别:
-
资助金额:$1099.06万
-
财政年份:2017
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:8830542
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2014
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:9108435
-
项目类别:
-
资助金额:$75.75万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:8422894
-
项目类别:
-
资助金额:$68.96万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:9270134
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:8722602
-
项目类别:
-
资助金额:$73.17万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
Microbial induction of sarcoidosis CD4+ T cell dysfunction
-
批准号:9043520
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2013
-
负责人:Gordon R Bernard
-
依托单位:
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:8499470
-
项目类别:
-
资助金额:$67.32万
-
财政年份:2012
-
负责人:Gordon R Bernard
-
依托单位:
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
-
批准号:9308216
-
项目类别:
-
资助金额:$11.05万
-
财政年份:2012
-
负责人:Gordon R Bernard
-
依托单位:
海外基金